Sarah Dewitt
Stock Analyst
(n/a)
# 1,327
Out of 4,648 analysts
13
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Sarah Dewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GSHD Goosehead Insurance | Downgrades: Neutral | $100 → $135 | $107.64 | +25.42% | 2 | Jul 1, 2021 | |
| RNR RenaissanceRe Holdings | Assumes: Underweight | $173 | $266.74 | -35.14% | 4 | Nov 12, 2019 | |
| ALL The Allstate Corporation | Reiterates: Overweight | $120 | $182.80 | -34.35% | 1 | May 2, 2018 | |
| CB Chubb | Upgrades: Overweight | n/a | $277.18 | - | 1 | Nov 8, 2017 | |
| BRK.B Berkshire Hathaway | Initiates: Overweight | $210 | $441.25 | -52.41% | 1 | Sep 14, 2017 | |
| AWH Aspira Women's Health | Downgrades: Neutral | n/a | $0.89 | - | 4 | Jan 6, 2017 |
Goosehead Insurance
Jul 1, 2021
Downgrades: Neutral
Price Target: $100 → $135
Current: $107.64
Upside: +25.42%
RenaissanceRe Holdings
Nov 12, 2019
Assumes: Underweight
Price Target: $173
Current: $266.74
Upside: -35.14%
The Allstate Corporation
May 2, 2018
Reiterates: Overweight
Price Target: $120
Current: $182.80
Upside: -34.35%
Chubb
Nov 8, 2017
Upgrades: Overweight
Price Target: n/a
Current: $277.18
Upside: -
Berkshire Hathaway
Sep 14, 2017
Initiates: Overweight
Price Target: $210
Current: $441.25
Upside: -52.41%
Aspira Women's Health
Jan 6, 2017
Downgrades: Neutral
Price Target: n/a
Current: $0.89
Upside: -